Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/06/1996 | EP0740504A1 Phytophthora resistance gene of catharanthus and its use |
11/06/1996 | EP0729361A4 Method of treating neurological disorders |
11/06/1996 | EP0652901A4 Carboxy terminal il-6 muteins. |
11/06/1996 | EP0590034B1 Method for determining the presence of diabetes associated antibodies or islet cell directed antibodies |
11/06/1996 | EP0485591B1 Method for isolating deletion mutants of vibrio cholerae and cultures containing vibrio cholerae |
11/06/1996 | CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains |
11/06/1996 | CN1135223A Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing same |
11/06/1996 | CN1135222A Aglucone isolflavone enriched vegetable protein concentrate and process for producing same |
11/06/1996 | CN1135214A Aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing same |
11/06/1996 | CN1135181A Alteration of immune response using pan Dr-binding peptides |
11/06/1996 | CA2175786A1 Igf-1 superagonists |
11/06/1996 | CA2175298A1 Recombinant obese (ob) proteins |
11/05/1996 | US5571940 Method for making conjugate moieties capable of chelating paramagnetic metals and designed for coupling with a factor responsive to specific cellular marker sites |
11/05/1996 | US5571905 Gene mutated in colorectal cancer of humans |
11/05/1996 | US5571904 Male flower specific gene sequences |
11/05/1996 | US5571900 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
11/05/1996 | US5571896 Production of recombinant human lactoferrin |
11/05/1996 | US5571895 Modified GAF polypeptides |
11/05/1996 | US5571893 Cardiac hypertrophy factor |
11/05/1996 | US5571797 Method of inducing gene expression by ionizing radiation |
11/05/1996 | US5571791 Modified polypeptide fragments of the glucocorticoid receptor |
11/05/1996 | US5571790 Having specified amino acid sequence and free of proteins of human origin; medical diagnosis; treatment of damaged blood vessels |
11/05/1996 | US5571787 Prosaposin as a neurotrophic factor |
11/05/1996 | US5571722 Plasmid for detecting mercury in water |
11/05/1996 | US5571718 Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7 |
11/05/1996 | US5571713 Therapeutic treatment for inhibiting vascular restenosis |
11/05/1996 | US5571712 Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats |
11/05/1996 | US5571711 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors |
11/05/1996 | US5571710 CDNA coding for carcinoembryonic antigen |
11/05/1996 | US5571706 Plant virus resistance gene and methods |
11/05/1996 | US5571702 Amplification method for detection of human PF4A receptors |
11/05/1996 | US5571698 Genetic package, chimeric |
11/05/1996 | US5571697 Plasmid dna sequences from cultures of fungal cells with promoters |
11/05/1996 | US5571696 Steroid or thyroid hormone receptor proteins |
11/05/1996 | US5571695 Dna and sequences for genomes |
11/05/1996 | US5571694 Expression of tetanus toxin fragment C in yeast |
11/05/1996 | US5571692 Retinoic acid receptor α, vectors and cells comprising the same DNA encoding |
11/05/1996 | US5571691 Genetic engineering with dna |
11/05/1996 | US5571688 Method of detecting gene expression |
11/05/1996 | US5571686 Method of using megapoietin for prolonging the survival & viability of platlets |
11/05/1996 | US5571679 Antiinflammatory agents and immunoassay |
11/05/1996 | US5571675 Detection and amplification of candiotrophin-1(cardiac hypertrophy factor) |
11/05/1996 | US5571674 DNA oligomers for use in detection of campylobacter pylori and methods of using such DNA oligomers |
11/05/1996 | US5571672 Gypsy moth genotype assay |
11/05/1996 | US5571514 Immunization by forming antibody proteins |
11/05/1996 | US5571509 Protein |
11/05/1996 | US5571508 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
11/05/1996 | US5571507 Methods of treating diabetes |
11/05/1996 | US5571500 Treatment of autoimmune diseases through administration by inhalation of autoantigens |
11/05/1996 | US5571499 Treatment of diseases with autoimmune fragments and collagen |
11/02/1996 | CA2172918A1 Prion inactivation in connective tissue materials |
10/31/1996 | WO1996034288A1 Human brain sodium-dependent inorganic phosphate cotransporter |
10/31/1996 | WO1996034117A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
10/31/1996 | WO1996034113A2 Methods for the identification of farnesyltransferase inhibitors |
10/31/1996 | WO1996034111A1 Process for preparing anti-obesity protein |
10/31/1996 | WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
10/31/1996 | WO1996034106A1 Decorin binding protein compositions and methods of use |
10/31/1996 | WO1996034105A1 Modified polypeptides for enhanced immunogenicity |
10/31/1996 | WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
10/31/1996 | WO1996034102A1 Purified mammalian t cell antigen crtam |
10/31/1996 | WO1996034101A1 Utrophin gene promoter |
10/31/1996 | WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
10/31/1996 | WO1996034097A1 GENE-TARGETED NON-HUMAN MAMMALS DEFICIENT IN SOD-1 GENE AND EXPRESSING HUMANIZED Aβ SEQUENCE WITH SWEDISH FAD MUTATION |
10/31/1996 | WO1996034095A1 Human tumor necrosis factor receptors |
10/31/1996 | WO1996034094A1 Non-human transgenic animal with modified d2 receptor expression |
10/31/1996 | WO1996034088A2 Control of floral induction in plants and uses therefor |
10/31/1996 | WO1996034016A1 Novel polypeptides |
10/31/1996 | WO1996034014A1 Bacteriocins produced by ruminal bacteria |
10/31/1996 | WO1996034013A1 Antigen peptide compound and immunoassay method |
10/31/1996 | WO1996034009A1 Chimeric nucleic acids and proteins for inhibiting hiv-1 expression |
10/31/1996 | WO1996033737A1 Peptide-based vaccine against papillomavirus infection |
10/31/1996 | WO1996033736A1 Malaria peptides and vaccines |
10/31/1996 | WO1996033733A1 Novel remedy for skin deficiencies |
10/31/1996 | WO1996033730A2 Chemokine binding protein and methods of use therefor |
10/31/1996 | WO1996027676A3 Method and means for the production of gene products, novel recombinant dna vectors therefor and kits employing them |
10/31/1996 | WO1996021011A3 PEPTIDES SPECIFIC FOR THE FIRST Crk-SH3 DOMAIN |
10/31/1996 | WO1996017627A3 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
10/31/1996 | WO1991000046A3 Method and apparatus for preparing fibrinogen adhesive from whole blood |
10/31/1996 | DE19516673A1 Vaccines against human, pref. mucin expressing, tumours |
10/31/1996 | CA2219221A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
10/31/1996 | CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
10/31/1996 | CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof |
10/31/1996 | CA2218987A1 Modified polypeptides for enhanced immunogenicity |
10/31/1996 | CA2218880A1 Process for preparing anti-obesity protein |
10/31/1996 | CA2218492A1 Decorin binding protein compositions and methods of use |
10/31/1996 | CA2216532A1 Inhibitors of farnesyl-protein transferase |
10/31/1996 | CA2214500A1 Control of floral induction in plants and uses therefor |
10/31/1996 | CA2194070A1 Novel polypeptides |
10/30/1996 | EP0739984A1 Bivalent polypeptides containing at least two domains |
10/30/1996 | EP0739980A2 DNA encoding CD 19 |
10/30/1996 | EP0739904A1 Bispecific reagents for aids therapy |
10/30/1996 | EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use |
10/30/1996 | EP0739634A2 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same |
10/30/1996 | EP0739630A2 Process and apparatus for the simultaneous elimination of tumor necrosis factor aplha and bacterial lipopolysaccharides from whole blood and/or blood plasma |
10/30/1996 | EP0739420A1 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of clostridium perfringens and their application to the detection and numeration of these bacteriae |
10/30/1996 | EP0739414A1 Herpesvirus replication defective mutants |
10/30/1996 | EP0739413A1 Method of selecting specific bacteriophages |
10/30/1996 | EP0739411A1 Chromosomal expression of heterologous genes in bacterial cells |
10/30/1996 | EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
10/30/1996 | EP0739354A1 Compositions and methods using unbound mpl receptor for stimulating platelet production |